Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-1-5
pubmed:abstractText
Laboratory evidence suggests that many anticancer agents exert their effect by altering the ratio between apoptosis and cellular proliferation. The objective of this clinical study was to examine in vivo changes in apoptotic index (AI), Bcl-2 expression, proliferation (Ki-67 and S-phase fraction [SPF]), and ploidy as potential indicators of chemoresponsiveness.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2145-52
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:11147583-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11147583-Apoptosis, pubmed-meshheading:11147583-Biopsy, Needle, pubmed-meshheading:11147583-Breast Neoplasms, pubmed-meshheading:11147583-Carcinoma, pubmed-meshheading:11147583-Cell Division, pubmed-meshheading:11147583-Female, pubmed-meshheading:11147583-Flow Cytometry, pubmed-meshheading:11147583-Humans, pubmed-meshheading:11147583-Immunohistochemistry, pubmed-meshheading:11147583-Ki-67 Antigen, pubmed-meshheading:11147583-Methotrexate, pubmed-meshheading:11147583-Middle Aged, pubmed-meshheading:11147583-Mitoxantrone, pubmed-meshheading:11147583-Neoadjuvant Therapy, pubmed-meshheading:11147583-Ploidies, pubmed-meshheading:11147583-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:11147583-S Phase, pubmed-meshheading:11147583-Tumor Markers, Biological
pubmed:year
2000
pubmed:articleTitle
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.
pubmed:affiliation
Department of Biochemistry, Medicine and Computing, The Royal Marden Hospital, Sutton, Surrey, United Kingdom. jcchang@bcm.tmc.edu
pubmed:publicationType
Journal Article